Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function

BACKGROUND: Vaccine-elicited adaptive immunity is a prerequisite for control of SARS-CoV-2 infection. Multiple sclerosis (MS) disease-modifying therapies (DMTs) differentially target humoral and cellular immunity. A comprehensive comparison of the effects of MS DMTs on SARS-CoV-2 vaccine–specific im...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabatino, Joseph J., Mittl, Kristen, Rowles, William M., McPolin, Kira, Rajan, Jayant V., Laurie, Matthew T., Zamecnik, Colin R., Dandekar, Ravi, Alvarenga, Bonny D., Loudermilk, Rita P., Gerungan, Chloe, Spencer, Collin M., Sagan, Sharon A., Augusto, Danillo G., Alexander, Jessa R., DeRisi, Joseph L., Hollenbach, Jill A., Wilson, Michael R., Zamvil, Scott S., Bove, Riley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876469/
https://www.ncbi.nlm.nih.gov/pubmed/35030101
http://dx.doi.org/10.1172/jci.insight.156978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876469/
https://www.ncbi.nlm.nih.gov/pubmed/35030101
http://dx.doi.org/10.1172/jci.insight.156978

Ejemplares similares